The "Cognition and Memory Enhancement Drugs: Technologies and Global Markets" report has been added to ResearchAndMarkets.com's offering.
This research report presents an in-depth analysis of the global cognition and memory-enhancing drugs market by application, product categories, and regional markets. The report includes key cognition drugs that are incorporated in several therapeutic treatment methods. It discusses the role of supply chain members from manufacturers to researchers.
The report has an in-depth analysis of key companies operating in the global cognition and memory-enhancing drugs market. In-depth patent analysis in the report will focus on providing extensive technological trends across years and regions such as the U.S., Europe, and China.
The cognition and memory-enhancing drugs market is segmented mainly into eight components: Aricept, Exelon, Reminyl, Namenda, Adderall, Ritalin, Dexedrin, and other cognition drugs. This market is further segmented on the basis of applications, which helps in understanding the potency of these memory enhancers in several therapeutic treatments.
The market study is detailed for products based on applications as well as its further implication on the research and development area. These two segmentations are also discussed in detail for the given period. The market is segmented by region into the North America, Europe, Asia-Pacific, and ROW.
Key Topics Covered
Chapter 1 Introduction
Chapter 2 Summary and Highlights
Chapter 3 Market and Technology Background
Chapter 4 Global Cognition and Memory-Enhancing Drugs Market Breakdown by Product Type
Chapter 5 Global Cognition and Memory-Enhancing Drugs Market Breakdown by Application
Chapter 6 Global Cognition and Memory-Enhancing Drugs Market Breakdown by Region
Chapter 7 Patent Review
Chapter 8 Analysis of Market Opportunities
Chapter 9 Company Profiles
Chapter 10 Appendix: Patents, Drugs and Cognitive Enhancers
For more information about this report visit https://www.researchandmarkets.com/research/vfskvq/cognition_and?w=4
View source version on businesswire.com: https://www.businesswire.com/news/home/20180711005428/en/